SHW
The Sherwin-Williams Company
(NYSE: SHW)
Balfour Capital Group has issued a buy recommendation
for The Sherwin-Williams Company (SHW)Â on April 7th, 2025
The Sherwin-Williams Company is a global leader in the development, manufacture, and sale of paints, coatings, and related products. Founded in 1866 by Henry Sherwin and Edward Williams in Cleveland, Ohio, the company has expanded its operations to over 120 countries. Sherwin-Williams offers a wide range of products, including architectural paints, industrial coatings, and floorcoverings, catering to professional, industrial, retail, and commercial customers.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $332.06 on April 7th, 2025.
- Our designated price target stands at $400.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
Balfour Capital Group wants to clarify that our recommendation to Buy The Sherwin-Williams Company (NYSE: SHW)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
A
Agilent Technologies, Inc.
(NYSE: A)
Balfour Capital Group has issued a buy recommendation
for Agilent Technologies, Inc. (A)Â on April 3rd, 2025
Agilent Technologies, Inc. is an American company that provides instruments, software, services, and consumables for laboratories worldwide. Established in 1999 as a spin-off from Hewlett-Packard, Agilent supports scientists in over 110 countries, focusing on life sciences research, patient diagnostics, and safety testing for water, food, and pharmaceuticals. The company’s product portfolio includes automation, bioreagents, gas and liquid chromatography, mass spectrometry, spectroscopy, and vacuum technologies.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $113.99 on April 3rd, 2025.
- Our designated price target stands at $180.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Agilent Technologies, Inc. (NYSE: A)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
CCL
Carnival Corporation & plc
(NYSE: CCL)
Balfour Capital Group has issued a buy recommendation
for Carnival Corporation & plc (CCL)Â on March 31st, 2025
Carnival Corporation & plc is the world’s largest cruise company, operating a portfolio of leading cruise brands across North America, Europe, Asia, and Australia. Its brands include Carnival Cruise Line, Princess Cruises, Holland America Line, Seabourn, and Cunard. The company offers a wide range of vacation experiences and is a leading provider of leisure travel worldwide resources.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $19.81 on March 31st, 2025.
- Our designated price target stands at $33.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy Carnival Corporation & plc (NYSE: CCL)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
ACN
Accenture PLC
(NYSE: ACN)
Balfour Capital Group has issued a buy recommendation
for Accenture PLC (ACN)Â on March 31st, 2025
Accenture plc is a global professional services company specializing in information technology (IT) services and consulting. Headquartered in Dublin, Ireland, Accenture offers a broad range of services, including strategy and consulting, interactive, technology, and operations services. The company serves clients across more than 120 countries and operates in various industries, such as communications, media, technology, financial services, health and public service, products, and resources.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $304.33 on March 31st, 2025.
- Our designated price target stands at $375.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy Accenture PLC (NYSE: ACN)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
WING
Wingstop Inc.
(NASDAQ: WING)
Balfour Capital Group has issued a buy recommendation
for Wingstop Inc. (WING)Â on March 27th, 2025
Wingstop Inc. is a fast-casual restaurant chain specializing in cooked-to- order, hand-sauced, and tossed chicken wings, boneless wings, tenders, and chicken sandwiches. Complementary offerings include seasoned fries, hand-cut carrots and celery, and dips like ranch and bleu cheese. Founded in 1994 in Garland, Texas, Wingstop began franchising in 1997 and has since expanded to over 2,200 locations worldwide, operating primarily as a franchisor with approximately 98% of its restaurants owned and operated by independent franchisees.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $220.08 on March 27th, 2025.
- Our designated price target stands at $275.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
Balfour Capital Group wants to clarify that our recommendation to Buy Wingstop Inc. (NASDAQ: WING)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
KMX
CarMax, Inc.
(NYSE: KMX)
Balfour Capital Group has issued a buy recommendation
for CarMax, Inc. (KMX)Â on March 27th, 2025
CarMax, Inc. is the largest used-car retailer in the United States. The company operates through two segments: CarMax Sales Operations and CarMax Auto Finance. CarMax Sales Operations is responsible for selling used vehicles, purchasing vehicles from consumers and dealers, and providing vehicle repair services. CarMax Auto Finance offers financing solutions for customers purchasing vehicles from CarMax. The company is headquartered in Richmond, Virginia.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $75.90 on March 27th, 2025.
- Our designated price target stands at $95.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q3 EARNING REPORT
A Q3 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy CarMax, Inc. (NYSE: KMX)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
META
Meta Platforms, Inc.
(NASDAQ: META)
Balfour Capital Group has issued a buy recommendation
for Meta Platforms, Inc. (META)Â on March 27th, 2025
Meta develops products that enable people to connect and share experiences across various devices. Its offerings include Facebook, Instagram, Messenger, WhatsApp, and virtual reality products through its Reality Labs division. The company focuses on building the “metaverse, ” an integrated environment linking its products and services.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $611.75 on March 27th, 2025.
- Our designated price target stands at $890.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy Meta Platforms, Inc. (NASDAQ:META)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
LYV
Live Nation Entertainment, Inc.
(NYSE:LYV)
Balfour Capital Group has issued a buy recommendation
for Live Nation Entertainment, Inc. (LYV)Â on March 17th, 2025
Live Nation Entertainment, Inc. is a leading American multinational entertainment company, formed in 2010 through the merger of Live Nation and Ticketmaster. The company specializes in promoting, operating, and managing ticket sales for live entertainment events worldwide. Its operations encompass concert promotion, venue management, ticketing services through Ticketmaster, and artist management. Live Nation owns and operates numerous venues globally and manages the careers of various music artists.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $118.40 on March 17th, 2025.
- Our designated price target stands at $145.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Live Nation Entertainment, Inc. (NYSE:LYV)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
BNTX
BioNTech SE
(NASDAQ: BNTX)
Balfour Capital Group has issued a buy recommendation
for BioNTech SE (BNTX)Â on March 17th, 2025
BioNTech SE is a biotechnology company specializing in the development of immunotherapies for cancer and infectious diseases. The company’s product portfolio includes investigational mRNA vaccines, protein-based therapeutics, cell therapies, and small molecules. BioNTech collaborates with multiple global pharmaceutical companies, including Pfizer, to develop mRNA-based vaccines.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $99.70 on March 17th, 2025.
- Our designated price target stands at $130.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
Balfour Capital Group wants to clarify that our recommendation to Buy BioNTech SE (NASDAQ: BNTX)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
KTB
Kontoor Brands, Inc.
(NYSE: KTB)
Balfour Capital Group Researched Kontoor Brands, Inc (KTB) on March 7th, 2025.
Kontoor Brands, Inc. is a lifestyle apparel company that designs, manufactures, sources, markets, and distributes denim, apparel, footwear, and accessories. The company’s primary brands include Wrangler and Lee, offering a range of products such as jeans, pants, shirts, shorts, and jackets for adults and children. Kontoor Brands operates through various distribution channels, including mass merchants, specialty stores, department stores, company-operated stores, and online platforms. The company serves markets in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions.
Post Recommendation Price Trend Chart
- We have established a Sell recommendation at $61.17 on March 7th, 2025.
- Our designated price target stands at $37.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Sell Kontoor Brands, Inc. (NYSE: KTB) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
